The 2021 European Alliance of Associations for Rheumatology/American College of Rheumatology points to consider for diagnosis and management of autoinflammatory type I interferonopathies: CANDLE/PRAAS, SAVI and AGS
Kader Cetin Gedik(National Institutes of Health), Raphaela Goldbach‐Mansky(National Institutes of Health), Laura Adang(Children's Hospital of Philadelphia), Bénédicte Neven(Université Paris-Panthéon-Assas), Simona Orcesi(Fondazione Istituto Neurologico Nazionale Casimiro Mondino), Adeline Vanderver(Children's Hospital of Philadelphia), Yanick J. Crow(Institute of Genetics and Cancer), Kathe Barchus(Digital Research Alliance of Canada), Davide Tonduti, Brian M. Feldman(Washington University in St. Louis), M. Cecilia Poli(Universidad del Desarrollo), David Piskin(Western University), Devon Cordova(ME Association), Karen Durrant(Kaiser Permanente San Francisco Medical Center), Micol Romano, Elliot Schumacher(Digital Research Alliance of Canada), Min Ae Lee‐Kirsch(Klinik und Poliklinik für Kinder- und Jugendmedizin), Russell C. Dale(Children's Hospital at Westmead), Paul Brogan(Great Ormond Street Hospital), Daniel Aletaha(Medical University of Vienna), Francesco Gavazzi(Children's Hospital of Philadelphia), Elisa Fazzi(Centro Studi GISED), Lovro Lamot, Marco Gattorno(Istituto Giannina Gaslini), Gina A. Montealegre Sanchez(National Institute of Arthritis and Musculoskeletal and Skin Diseases), Seza Özen(Hacettepe University), Thaís Armangué(Universitat de Barcelona), Sofia Torreggiani(National Institutes of Health), Eric P. Hanson(Riley Hospital for Children), Erkan Demirkaya(Western University), Despina Eleftheriou(Great Ormond Street Hospital), Katsiaryna Uss(National Institutes of Health)
Cited by 97
Related Papers
2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative
|Arthritis & Rheumatism|2010|9.5k
A clinical approach to diagnosis of autoimmune encephalitis
|The Lancet Neurology|2016|4.4k
Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
|The Lancet Neurology|2013|3.1k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update
|Annals of the Rheumatic Diseases|2020|2.8k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k